ProQR will host a virtual Investor and Analyst Event highlighting its pipeline entitled:
“Expanding the Axiomer™ RNA Editing Opportunity Beyond AX-0810”
Ahead of the anticipated target engagement data for AX-0810 in the first half of 2026, the Company will showcase ProQR’s broader RNA editing pipeline at this event, announce new programs that will have clinical data readouts in the runway, and unveil the primary indication for AX-0810.
Event Details and Registration
• Title: Expanding the Axiomer™ RNA Editing Opportunity Beyond AX-0810
• Date & Time: April 8, 2026 beginning at 10:00 am ET until approximately 11:30 am ET
• Virtual format: Webcast presentations and Q&A with covering analysts and Management
• Registration: https://lifescievents.com/event/g09gufqylu/
